World Vaccine Congress 2015: Industry Insights

The World Vaccine Congress  is the  premier event in the vaccine calendar. It is the place where the vaccine industry meets to discuss scientific and commercial issues around vaccine research, development, manufacture and distribution. With only seven weeks to go till the event, we’re getting pretty excited and we hope you are too!  We’ve been in touch with a few of our …

IP, Pharma, Generics, Opportunities, Challenges, Europe,

IP in Pharma Generics Opportunities & Challenges in the EU

At the World Generic Medicines Congress Europe 2014, Thomas Kolzau, Helm AG, gave a presentation entitled “IP in Pharma Generics Opportunities & Challenges in the EU” Download and learn: Opportunities – pharma generics Challenges – pharma generics Oppositions in the generic market Appeals in the generic market Settlement Manufacturing & stockpiling Importance of the EU generics industry Impact of a manufacturing …

Europe, US, Transatlantic, Trade, Investment, Agreement, Generics

EU-US Transatlantic Trade and Investment Agreement (TTIP) Impact on the Generics Industry

At the World Generic Medicines Congress Europe 2014, Michel Mikail, Fresenius Kabi, gave a presentation on “EU-US Transatlantic Trade and Investment Agreement (TTIP) Impact on the Generics Industry”. Download and learn: EU-US Transatlantic Trade & Investment Partnership (TTIP) Intellectual Property Rights Other ongoing negotiations FTAs’ opportunities and challenges Download presentation  Found this interesting? Join us at the 9th annual World Generic Medicines Congress Europe, …

Value, European, Healthcare, Market

How to develop a compelling value proposition in the current European healthcare market

At Evidence EU 2014, Caroline Gadd, Otsuka Pharmaceuticals, gave a presentation on “How to develop a compelling value proposition in the current European healthcare market”. Gadd’s presentation highlights the importance of value proposition, demonstrating that a successful proposition is moving towards a customer centric approach as well as being able to support the whole market. Download and Learn: The value proposition as …

Download: From Safety Governance to Benefit Risk Governance

At last year’s World Drug Safety Congress Europe, Peter Verdru, MD, Safety Sciences, UCB gave a presentation on “From Safety Governance to Benefit Risk Governance.” Verdru mentions that the continuous safety profile monitoring and benefit risk evaluation of authorised medicinal products is critical to pharmacovigilance processes.  He goes on to discuss in depth, Benefit Risk Teams, Benefit Risk membership, Benefit Risk board …

Whitepaper: The Pharmaceutical industry and the UK Bribery Act

  The UK Bribery Act (UKBA) puts particular pressure on pharmaceutical companies. Already operating in a highly regulated environment, due to the nature of their business pharma companies are active and associate with third parties in various locales around the world, and often have many bureaucratic hurdles to overcome. This paper discusses the particular vulnerabilities of the industry in light …

compliance, cee, europe, regulation, pharma, pharmaceutical, industry, interview, ebook

Download ebook: Compliance Challenges & Conclusions

Predictions and tips to benchmark and drive your compliance programme CEE is regarded as a strong growth market for pharma, but operating in the region comes with its own challenges. In an era of changing social environment and a growing demand for increasing transparency, compliance faces a raft of challenges in this region including working with distributors, managing risk, understanding local …

Download ebook: Top 10 influencers in European evidence development

We have compiled a list of the Top 10 influencers in European evidence development. They have been chosen based on their experience, career achievements and contributions to evidence development. Download ebook We’ve compiled this list during the development of the Evidence EU conference, taking place in London on 25th – 26th February this year. For more information about this event …

Researchers challenge ban on embryonic stem cell patents

Scientists and lawyers in Britain are challenging the European ban on patenting embryonic stem cells, according to an article in The Independent newspaper. The ban came into being in October 2011, when the European Court of Justice ruled that procedures involving human embryonic stem (ES) cells cannot be patented. At the time, many scientists were incensed. “This is the worst …

Download Ebook: Top 5 biggest challenges in Pharma compliance

The increasing number of transparency regulations in Pharma and anti-corruption & anti-bribery laws are beginning to resemble legislation in the United States. The risk of severe fines and a tarnished reputation means companies need to make sure they are managing risk and implementing a comprehensive compliance programme. But what are the key challenges faced by compliance professionals in pharma? From …